Jasmine Luzum, PharmD, PhD, FHFSA, FAHA
She/Her
Pharmacy
Dr. Luzum joined the University of Michigan in July 2016. She received her PharmD summa cum laude from the University of Pittsburgh in 2008 and her PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy in 2013. She completed a Post-Doctoral Fellowship at the Ohio State University College of Medicine and Center for Pharmacogenomics in 2016. She became a Board-Certified Pharmacotherapy Specialist by the Board of Pharmacy Specialties and an Applied Pharmacologist by the American Board of Clinical Pharmacology in 2015.
Projects:
Pharmacogenetics of anticoagulants, Pharmacogenetics of drug-induced QT prolongation & arrhythmias, Pharmacogenetics of heart failure medications, Pharmacogenetics of statins, Race disparities in cardiovascular medication outcomes
University Affiliation(s)
Frankel Cardiovascular Center | IHPI | MICHR
Community and Professional Affiliation(s)
American Heart Association | American Society for Clinical Pharmacology & Therapeutics | Clinical Pharmacogenetics Implementation Consortium
Research Area(s)
Pharmacogenomics | cardiovascular diseases
Publications
- Physicians' attitudes toward pharmacogenetic testing before and after pharmacogenetic education
- The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems
- Institutional profile of pharmacogenetics within University of Michigan College of Pharmacy
Grants
- Mentor of: Bleeding on Direct Oral Anticoagulants: Identification of Genetic Risk Factors and a Polygenic Predictive Score in Patients with Atrial Fibrillation
- Mentor of: Bleeding on Direct Oral Anticoagulants: Identification of Genetic Risk Factor and a Polygenic Predictive Score in Patients with Atrial Fibrillation
- Mentor of: Drug-Induced Long QT Syndrome: Determining the Associations of Candidate Genetic Variants and a Polygenic Score with diLQTS Risk